In this article
- Why Cartilage Damage Doesn’t Heal on Its Own
- What Osteochondral Allograft Transplantation Involves
- What Cartilage Cell Transplantation Involves
- How Defect Size and Location Shape the Decision
- Graft Survival and Long-Term Outcomes
- Where Recovery Timelines Differ
- Why Individualized Evaluation Matters Most
- Frequently Asked Questions
- Resources
Osteochondral allograft transplantation and cartilage cell transplantation both restore focal cartilage damage in the knee, but they work differently. An allograft uses donor cartilage and bone in one surgery and suits larger defects with bone loss, while cell transplantation uses the patient’s own cells over two surgeries and is often favored for contained defects. The right repair depends on the specific characteristics of the injury, not a one-size-fits-all default.
Cartilage damage in the knee can take different forms. A focal cartilage defect is a specific damaged area in an otherwise healthy joint, while arthritis typically involves more widespread wear. Because these conditions differ, the treatment approach differs as well, as explained in Cartilage Damage vs. Arthritis. Osteochondral allograft transplantation and cartilage cell transplantation are two procedures designed to restore focal cartilage damage, and each works in its own way. This article explains how each procedure works, which types of defects tend to suit each, and why careful patient selection plays such an important role in outcomes.
Why Cartilage Damage Doesn’t Heal on Its Own
Articular cartilage, the smooth tissue covering the ends of bones within a joint, has a very limited blood supply, so it lacks the capacity to repair itself the way skin or bone does. Left untreated, focal cartilage defects can worsen over time and contribute to early osteoarthritis, particularly in younger, active patients whose knees face years of continued loading. That is why surgical restoration, rather than simply managing symptoms, becomes an important consideration when the damage is localized. More background on knee cartilage restoration is available on the practice site.
What Osteochondral Allograft Transplantation Involves
Osteochondral allograft transplantation (OCA) replaces the damaged cartilage and the bone beneath it with donor tissue that has been processed, preserved, and matched to the size and location of the defect. A 2025 paper by Dr. Cole and colleagues consolidated 25 years of translational and clinical research on the technique, drawing on more than 1,500 procedures and covering graft procurement, preservation, handling, and surgical technique. Once considered a niche procedure performed at a few academic centers, OCA is now a reproducible, widely adopted method of cartilage restoration.
Because a single graft restores both the cartilage and its supporting bone, OCA is particularly well suited to larger defects and to defects with bone loss beneath the cartilage surface.
What Cartilage Cell Transplantation Involves
Cartilage cell transplantation, formally known as autologous chondrocyte implantation (ACI), takes a different approach. Instead of using donor tissue, it uses the patient’s own cartilage cells. A small sample of healthy cartilage is harvested during an initial arthroscopic procedure, the cells are expanded in a laboratory, and they are implanted into the defect during a second surgery, today typically on a supporting membrane. Because the repair tissue comes from the patient’s own cells, this approach can be appealing for patients who prefer to avoid donor tissue, though it requires a staged, two-surgery process.
How Defect Size and Location Shape the Decision
The choice often comes down to the characteristics of the defect itself. Larger or irregularly shaped defects, particularly those with significant bone loss beneath the cartilage, tend to be better suited to OCA, since it restores bone and cartilage in one setting. Cell transplantation is often favored for contained defects limited to the cartilage, where the underlying bone is healthy.
Surgical technique continues to evolve. For multifocal or large, irregular defects, approaches such as multiple overlapping plugs (sometimes called a snowman technique) or newer single oblong grafts allow surgeons to better match the graft to complex defect shapes.
Graft Survival and Long-Term Outcomes
Long-term data plays a meaningful role in the decision. In a study from Dr. Cole’s group following 160 patients for an average of nearly eight years after OCA of the femoral condyles, graft survival was 86.2 percent at five years and 81.8 percent at ten years. Reoperations were common, at about 39 percent, but most patients who needed a reoperation did not go on to graft failure. Athletes in the study were less likely to experience failure. Grafts are now often augmented with bone marrow aspirate concentrate (BMAC), which a randomized trial from Dr. Cole’s group linked to fewer reoperations, as described in Orthobiologics Explained: PRP vs. BMAC.
Where Recovery Timelines Differ
Recovery expectations differ between the two approaches. Because cell transplantation involves a cell harvest followed by a later implantation surgery, the overall treatment timeline is generally longer than the single-surgery approach of OCA. Patients weighing these options should talk candidly with their surgeon about how each timeline fits their personal, athletic, or professional circumstances, since a return to high-level activity takes time with either approach.
Why Individualized Evaluation Matters Most
Neither technique is universally superior. The right choice depends on defect size, location, depth of bone involvement, knee alignment and meniscus health, patient age, and activity goals. A thorough evaluation, often including advanced imaging to fully characterize the defect, helps determine which technique is most likely to provide a durable result for a specific patient, rather than defaulting to a single approach for every case of cartilage damage. Evaluation by a surgeon experienced in cartilage restoration can clarify which option fits a particular knee and set of goals. If you are dealing with a knee cartilage defect, requesting an appointment online is a reasonable next step.
Frequently Asked Questions
What is the main difference between an osteochondral allograft and cartilage cell transplantation?
An osteochondral allograft uses donor cartilage and bone and is done in one surgery. Cartilage cell transplantation uses the patient’s own cartilage cells, grown in a laboratory, and requires two surgeries.
Which option is better for large defects with bone loss?
Osteochondral allografts are generally better suited to larger defects and those involving the bone beneath the cartilage, because they restore both layers at once.
How long do osteochondral allografts last?
In one long-term study, about 86 percent of grafts were still in place at five years and about 82 percent at ten years.
Why does cartilage cell transplantation take longer?
It requires an initial procedure to harvest cells, a laboratory growth period, and then a second surgery to implant them.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Cole or another qualified orthopedic specialist at Midwest Orthopaedics at Rush.
Resources
Cole BJ et al. 2025. Optimizing patient outcomes following osteochondral allograft transplantation: the impact of 25 years of translational and clinical research. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.26089
Gilat R et al. 2021. Osteochondral allograft transplant for focal cartilage defects of the femoral condyles: clinically significant outcomes, failures, and survival at a minimum 5-year follow-up. The American Journal of Sports Medicine. https://doi.org/10.1177/0363546520980087
Yanke AB et al. 2025. Bone marrow aspirate concentrate may decrease reoperation in osteochondral allograft transplantation: a prospective, randomized, double-blind investigation. Arthroscopy. https://doi.org/10.1016/j.arthro.2025.05.024
